vitamin k 3 has been researched along with Hyperplasia in 1 studies
Vitamin K 3: A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo.
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Long, DJ | 1 |
| Iskander, K | 1 |
| Gaikwad, A | 1 |
| Arin, M | 1 |
| Roop, DR | 1 |
| Knox, R | 1 |
| Barrios, R | 1 |
| Jaiswal, AK | 1 |
1 other study available for vitamin k 3 and Hyperplasia
| Article | Year |
|---|---|
Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity.
Topics: Animals; Base Sequence; Bone Marrow; Cloning, Molecular; DNA Primers; Fertility; Flow Cytometry; Hyp | 2002 |